LIAISON NES
LIVE

Serial Number

79383235

Owner

DIASORIN S.P.A.

Attorney

Ben Natter

Filing Date

Jul 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LIAISON NES Trademark

Serial Number: 79383235 • Registration: 7525844

LIAISON NES is a trademark filed by DIASORIN S.P.A. on July 28, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

DIASORIN S.P.A. (15 trademarks)

VIA CRESCENTINO SNC
SALUGGIA, VERCELLI 13040 , IT

Entity Type: 09

Trademark Details

Filing Date

July 28, 2023

Registration Date

October 8, 2024

Published for Opposition

July 23, 2024

Goods & Services

Downloadable computer software mobile applications for use in diagnosing individuals; Downloadable computer software for medical diagnostics and for operating diagnostic apparatus that is not for medical purposes; Testing machines and instruments for diagnostic purposes, other than for medical use, namely apparatuses composed of PC tablets and optical readers for testing liquids and solids; Downloadable portable and cloud-connected point of care (POC) immunodiagnostic software platforms for diagnosing individuals; Downloadable computer software and hardware for the design, creation and control of tools for medical diagnostics; Downloadable software for processing data; Apparatus, equipment, hardware and computers for diagnostics; Data storage, processing and transmission apparatus for diagnostic purposes, namely, blank tapes for storing computer data; Data processing equipment, namely, optical readers for diagnostic purposes; PC tablets used for test and diagnostic purposes; Video monitors; Testing apparatus not for medical purposes, namely, apparatus for testing liquids and solids; Measuring or testing machines and instruments for diagnostic purpose, other than for medical use, namely, apparatus composed of PC tablets and optical readers for testing liquids and solids; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids

Diagnostic testing apparatus for medical purposes for testing biomarkers and biomolecules; Medical diagnostic apparatus for medical purposes; Tools for medical diagnostics, namely, medical diagnostic apparatus for testing for viruses and infectious disease; Medical devices for diagnosing viruses; Medical testing equipment, namely, medical device for detecting antibodies against SARS-CoV-2; Medical apparatus for medical analysis of bacteria; Electronic analyzers for bacterial identification for medical purposes; Apparatus for taking blood samples; Apparatus for taking body fluid samples; Point of care (POC) diagnostic, examination and monitoring equipment, namely, respiratory equipment and monitors therefor; Point of care (POC) immunochemical testing apparatus for carrying out diagnostic tests for medical purposes; Diagnostic apparatus for the identification of specific antibodies against SARS-CoV-2 in capillary blood samples; Diagnostic apparatus for the identification of virus, bacterial infections and infectious diseases; Radiological diagnostic imaging apparatus for medical purposes in the field of immunochemistry; Medical diagnostic apparatus for testing for viruses; Apparatus for DNA and RNA testing for medical purposes; Syringes for injections; Extraction medical syringes; Disposable hypodermic syringes for medical use; Medical syringe needles; Medical diagnostic apparatus for the identification of respiratory infections in the nature of influenza, SARS-CoV-2 and Group A streptococcus; Medical diagnostic apparatus for the identification of sexually transmitted infections; Molecular platform designed for the detection of pathogens causing infectious diseases through PCR nucleic acid amplification technology

Medical diagnostic test reagents for testing body fluids for veterinary use; Medical diagnostic test reagents for testing body fluids for medical purposes; Diagnostic agents for medical use; Chemical reagents for medical or veterinary purposes; Diagnostic kits comprising medical diagnostic bioagents for extracting, testing and analyzing body fluids; Diagnostic test kits comprising medical diagnostic reagents and assays for testing of body fluids for use in disease detection, namely, infectious disease, and detection of biological parameters; Diagnostic testing materials for medical use, namely, medical diagnostic test strips for use in the field of infectious diseases and detection of biological parameters; Medical diagnostic test strips for blood analysis; Virus testing preparations for medical use; Medical diagnostic assays for medical use; In vitro medical diagnostic tests for use in disease testing; In vitro medical diagnostic assays for use in disease testing; In vitro medical diagnostic test kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; In vitro medical diagnostic test strips for blood analysis; In vitro medical diagnostic reagents; Medical diagnostic test strips for the detection, diagnosis, screening and confirmation of viruses and infections; Reagents and test strips for medical purposes for use as indicators of disease and such indicators being antigens and antibodies; Immunoassay reagents for medical use; Biological and chemical preparations and reagents for medical or veterinary purposes for the detection of infectious diseases; Biochemical preparations for medical or veterinary purposes for the detection of infectious diseases; Bacterial preparations for medical and veterinary use; Nucleic acid sequences for medical and veterinary purposes; Medical diagnostic regents for the detection of pathogens responsible for respiratory infections in the nature of influenza, COVID-19 and Group A streptococcus; Medical diagnostic reagents for the detection of pathogens responsible for sexually transmitted infections

Chemicals used in science; Chemical diagnostic reagents for scientific purposes; Diagnostic preparations, other than for medical or veterinary purposes; Reagent bearing diagnostic strips for testing of infectious diseases and organic molecules, other than for medical or veterinary use; Diagnostic testing materials, other than for medical use in the nature of reagent bearing diagnostic strips for testing saliva; Control preparations, namely, chemical control solutions for in vitro diagnostic testing, screening, confirmation and analysis for laboratory or research use; Diagnostic reagents and chemical reagents for scientific or research purposes; Solutions in the nature of chemical control solutions used in diagnostic test kits for laboratory or research purposes; Chemically treated non-medical test strips for laboratory or research purposes; Diagnostic preparations for laboratory or research use; Diagnostic preparations for use in assessment of toxicological property of chemical compounds and mixture for scientific use; Diagnostic biomarkers for analytical, research and scientific use; Diagnostic preparations for in vitro testing for scientific use; nucleic acids; nucleic acids for scientific purposes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 25, 2025 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 3, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 15, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 15, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 4, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 19, 2025 FICS
FINAL DISPOSITION PROCESSED
Mar 19, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 8, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 8, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 8, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 14, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 15, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 9, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 9, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 14, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 13, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 13, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 21, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 16, 2023 REPR